Explore Our Network

Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.

Showing 3 Patents
Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

16-01-2018 • US-9867830-B2

WAINER, IRVING W. • MOADDEL, RUIN • BERNIER, MICHEL • ZARATE, CARLOS A. • TORJMAN, MARC C. • GOLDBERG, MICHAEL E. • TANGA, MARY J.

SRI International Inc • Cooper Health System Inc • Office of Technology Transfer

Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

16-05-2017 • US-9650352-B2

WAINER, IRVING W. • MOADDEL, RUIN • BERNIER, MICHEL • ZARATE, CARLOS A. • TORJMAN, MARC C. • GOLDBERG, MICHAEL E. • TANGA, MARY J.

SRI International Inc • Cooper Health System Inc • US Department of Health and Human Services

Compounds for activating TGF-β signaling

17-01-2012 • US-8097645-B2

WYSS-CORAY, ANTON • TANGA, MARY J.

SRI International Inc • US Department of Veterans Affairs • Leland Stanford Junior University

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.